| Description | Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. |
| Synonyms | Bendazac lysine, Bendazaco lisina, 苄达赖氨酸 |
| molecular weight | 428.48 |
| Molecular formula | C22H28N4O5 |
| CAS | 81919-14-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 2.41 mg/mL (5.62 mM), Sonication is recommended. |
| References | 1. Iuliano G, et al. Enzyme. 1989;42(4):235-7. |